Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Surg Pathol ; 45(6): 773-786, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33739791

ABSTRACT

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is an indolent small B-cell neoplasm that may transform into a clinically aggressive disease, namely Richter syndrome, usually as diffuse large B-cell lymphoma. Besides, CLL/SLL encompasses an increased risk of developing other secondary cancers, including a variety of T-cell lymphomas, often of the anaplastic large-cell type or with a cytotoxic phenotype. Here, we report a small series of patients with composite lymphomas consisting of CLL/SLL and angioimmunoblastic T-cell lymphoma (AITL), a hitherto unrecognized association. The 3 patients (1 male/2 females, 68 to 83 y) presented with high-grade-type symptoms. One patient was clinically suspicious for Richter syndrome, in the others CLL/SLL and AITL were concomitant de novo diagnoses. CLL/SLL and AITL were admixed in the same lymph nodes (3/3 cases) and in the bone marrow (1/2 cases). In all cases, the AITL comprised prominent clear cells with a strong T follicular helper immunophenotype and similar mutations consisting of TET2 or DNMT3A alterations, IDH2 R172K/M, and RHOA G17V. The 3 patients received chemotherapy. One died of early AITL relapse. The other 2 remained in complete remission of AITL, 1 died with recurrent CLL, and 1 of acute myeloid leukemia. These observations expand the spectrum of T-cell lymphoma entities that occur in association with CLL/SLL, adding AITL to the rare variants of aggressive neoplasms manifesting as Richter syndrome. Given that disturbances of T-cell homeostasis in CLL/SLL affect not only cytotoxic but also helper T-cell subsets, these may contribute to the emergence of neoplasms of T follicular helper derivation.


Subject(s)
Composite Lymphoma , Immunoblastic Lymphadenopathy , Leukemia, Lymphocytic, Chronic, B-Cell , Lymphoma, T-Cell , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/genetics , Composite Lymphoma/drug therapy , Composite Lymphoma/genetics , Composite Lymphoma/immunology , Diagnosis, Differential , Fatal Outcome , Female , Gene Rearrangement , Genes, T-Cell Receptor , Humans , Immunoblastic Lymphadenopathy/drug therapy , Immunoblastic Lymphadenopathy/genetics , Immunoblastic Lymphadenopathy/immunology , Immunoglobulins/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/immunology , Male , Predictive Value of Tests , Recurrence , Time Factors , Treatment Outcome
2.
Am J Surg Pathol ; 28(5): 679-86, 2004 May.
Article in English | MEDLINE | ID: mdl-15105659

ABSTRACT

Occurrence of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL), clinically referred to as Richter's syndrome, occasionally manifests as a lymphoproliferation resembling Hodgkin's lymphoma (HL) and often containing the Epstein-Barr virus (EBV). Only a limited number of HL variants have been subject to informative analysis regarding their clonal relationship to the CLL, with evidence of a same clonal origin in some cases and of clonally unrelated neoplasms in other cases. In this paper, we performed a detailed pathologic, virologic, and molecular analysis of two cases of Richter's syndrome with HL features. The first case occurred in a 65-year-old man with a 5-year history of CLL as a mediastinal and supraclavicular mass histologically diagnosed as lymphocyte depleted HL with no background CLL. The second case occurred in a 78-year-old woman with a 4-year history of CLL as an inguinal mass with a composite histologic appearance comprising areas of CLL, areas of CLL with Hodgkin Reed-Sternberg cells, and areas of HL. Both patients had received fludarabine therapy. The HRS cells were CD20-/CD30+/CD15-/J-chain- in case no. 1 and CD20+/-/CD30+/CD15-/J-chain- in case no. 2. In both cases, the Hodgkin's Reed-Sternberg cells (HRS) were positive for type A EBV, and a 30-bp deletion of the LMP-1 gene was detected in case no. 2. Using microdissection and polymerase chain reaction amplification of the immunoglobulin heavy chain gene (IgH) complementarity determining region III of each cell type, we demonstrated a distinct clonal origin for the CLL cells and the HRS in both cases. These cases bring support to the hypothesis that EBV+ HL in CLL patients occurs as unrelated secondary neoplasms most likely as the result of the immune depression associated with CLL and also raise the question of a possible causal role of fludarabine.


Subject(s)
Epstein-Barr Virus Infections/pathology , Herpesvirus 4, Human/physiology , Hodgkin Disease/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Neoplasms, Second Primary/pathology , Vidarabine/analogs & derivatives , Aged , Antineoplastic Agents/therapeutic use , Clone Cells , DNA, Neoplasm/analysis , Epstein-Barr Virus Infections/complications , Epstein-Barr Virus Infections/drug therapy , Female , Gene Deletion , Gene Rearrangement, B-Lymphocyte, Heavy Chain/genetics , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/isolation & purification , Hodgkin Disease/drug therapy , Hodgkin Disease/virology , Humans , Immunophenotyping , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/virology , Male , Neoplasms, Second Primary/complications , Neoplasms, Second Primary/drug therapy , Polymerase Chain Reaction , Reed-Sternberg Cells/pathology , Reed-Sternberg Cells/virology , Vidarabine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL